Results 251 to 260 of about 1,544,051 (390)

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the effectiveness of sodium‐glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase 4 (DPP‐4) inhibitors in reducing haemoglobin A1c (HbA1c) variability and improving cardiovascular and renal outcomes in patients with type 2 diabetes mellitus (T2DM) and high HbA1c variability.
Ran Guo   +18 more
wiley   +1 more source

Cataract Extraction in an English Population [PDF]

open access: bronze, 1965
F. I. Caird, Mark Hutchinson, A. Pirie
openalex   +1 more source

Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetes is increasingly reported as a cause of blindness and vision loss. However, the trends in the burden of blindness and vision loss attributed to diabetic retinopathy (DR) have yet to be fully elucidated. Materials and Methods Utilizing the latest data from the Global Burden of Disease Study 2021, we extracted prevalence and years ...
Yujie Pan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy